Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands		Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Beginning balance (in shares) at Jan. 31, 2021			76,340,000
Beginning balance at Jan. 31, 2021		$ 1,651,185	$ 764	$ 638,375	$ 1,019,762	$ (7,117)	$ (599)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		1,126,337			1,126,337
Foreign currency translation adjustments		(4,488)				(4,488)
Change in fair value of derivative financial instruments, net of tax		(247)				(247)
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		1,024				1,024
Conversion/release of stock-based awards (in shares)	[1]		745,000
Conversion/release of stock-based awards	[1]	(104,235)	$ 7	(103,742)			(500)
Repurchases of common stock (in shares)			(5,103,000)
Repurchases of common stock2		(899,433)	$ (51)	(26,806)	(872,576)
Reissuance of treasury stock under stock-based compensation plans	[1]	0		(344)	(44)		388
Stock-based compensation expense		93,459		93,459
Dividends declared		(199,395)			(199,395)
Ending balance (in shares) at Jan. 30, 2022			71,982,000
Ending balance at Jan. 30, 2022		1,664,207	$ 720	600,942	1,074,084	(10,828)	(711)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		1,127,904			1,127,904
Foreign currency translation adjustments		(3,572)				(3,572)
Change in fair value of derivative financial instruments, net of tax		932				932
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(341)				(341)
Conversion/release of stock-based awards (in shares)	[1]		668,000
Conversion/release of stock-based awards	[1]	(81,290)	$ 7	(80,925)			(372)
Repurchases of common stock (in shares)			(6,424,000)
Repurchases of common stock2		(880,038)	$ (64)	(36,134)	(843,840)		0
Reissuance of treasury stock under stock-based compensation plans	[1]	0		(344)	0		344
Stock-based compensation expense		89,578		89,578
Dividends declared		$ (216,329)			(216,329)
Ending balance (in shares) at Jan. 29, 2023		66,226,000	66,226,000
Ending balance at Jan. 29, 2023		$ 1,701,051	$ 663	573,117	1,141,819	(13,809)	(739)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		949,762			949,762
Foreign currency translation adjustments		(999)				(999)
Change in fair value of derivative financial instruments, net of tax		160				160
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(904)				(904)
Conversion/release of stock-based awards (in shares)	[1]		538,000
Conversion/release of stock-based awards	[1]	(52,831)	$ 5	(52,635)			(201)
Repurchases of common stock (in shares)	[2]		(2,613,000)
Repurchases of common stock2	[2]	(315,493)	$ (26)	(15,482)	(298,985)		(1,000)
Reissuance of treasury stock under stock-based compensation plans	[1]	0		(334)	(180)		514
Stock-based compensation expense		83,936		83,936
Dividends declared		$ (236,821)			(236,821)
Ending balance (in shares) at Jan. 28, 2024		64,151,000	64,151,000
Ending balance at Jan. 28, 2024		$ 2,127,861	$ 642	$ 588,602	$ 1,555,595	$ (15,552)	$ (1,426)

[1] Amounts are shown net of shares withheld for associate taxes.

[2] Repurchases of common stock include accrued excise taxes of $2.5 million as of January 28, 2024, which is recorded in retained earnings.